📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
45%
💰 Capital Raise
55%
• Critical: only 1.1 months cash remaining
📉 Score Deterioration
50%
• Score rose 41 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔄 Reverse Split
15%
• Only 1 months cash — financial pressure
💹 Market Data
Market Cap$5.13M
Shares Outstanding1.26M
Float546.3K
Cash$70.2K
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
6 institutional holders · 801 shares
#1
Jones Financial Companies, L.L.L.P.
313 shares
#2
UBS Group AG
247 shares
#3
Osaic Holdings Inc.
238 shares
+ 3 more holders Sign up free to view →
📉 Short Interest
Short Interest38.8K
Days to Cover1.0
% of Float7.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CHNR
📊 CHNR FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CHNR Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.